skipped a week of semaglutide Your Dose? What You Need to Know What Happens if You Skip

Start your intake How Semaglutide Timing Affects Your Body Semaglutide's long-acting mechanism means your injection day doesn't need to match a specific time of day to be effective

MEDVi is not affiliated with these manufacturers

W., Gabe, M

Key Takeaways Retatrutide (LY3437943) is an investigational weight loss medication developed by Eli Lilly Triple-agonist mechanism: First drug to activate GLP-1, GIP, and glucagon receptors simultaneously Phase 2 results: Up to 24.2% weight loss at 48 weeks (approximately 58 lbs for a 240-lb person) Not FDA-approved: Currently in Phase 3 clinical trials, expected approval in 20272028 How it differs: Outperforms semaglutide (Ozempic/Wegovy) and tirzepatide (Mounjaro/Zepbound) in weight loss trials Access now: Clinical trials (free), compounding pharmacies, or research peptide vendors What Is Retatrutide